Dashboard
Manage Tickers

STIMNeuronetics, Inc.

Nasdaq neurostar.com


$ 3.49 $ -0.03 (-0.85 %)    

Friday, 26-Apr-2024 15:59:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 3.49
$ 3.39
$ 0.00 x 0
$ 0.00 x 0
$ 3.34 - $ 3.52
$ 1.03 - $ 5.07
44,573
na
100.02M
$ 1.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-08-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-07-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-08-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-03-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 03-02-2021 12-31-2020 10-K
14 11-02-2020 09-30-2020 10-Q
15 08-04-2020 06-30-2020 10-Q
16 05-05-2020 03-31-2020 10-Q
17 03-03-2020 12-31-2019 10-K
18 11-05-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 03-05-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

neuronetics-inc-announces-new-publication-in-brain-stimulation-confirms-full-tms-treatment-course-is-vital
Neuronetics, Inc. Announces New Publicatio...
04/10/2024 12:39:13

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

top-5-health-care-stocks-that-may-plunge-in-march
Top 5 Health Care Stocks That May Plunge I...
03/28/2024 12:30:01

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/25/2024 13:05:53

neurostar-advanced-therapy-receives-fda-clearance-as-first-line-add-on-treatment-for-adolescents-with-depression
NeuroStar Advanced Therapy Receives FDA Cl...
03/25/2024 12:31:03

neuronetics-announces-5-year-exclusive-partnership-with-transformations-care-network
Neuronetics Announces 5-Year Exclusive Par...
03/07/2024 13:24:28

neuronetics-forecasts-q1-fy-2024-sales-of-167m-177m-and-78m-80m-for-2024-versus-consensus-of-1698m-and-7864m-respectively
Neuronetics Forecasts Q1 FY 2024 Sales Of ...
03/05/2024 12:33:34

neuronetics-q4-gaap-eps-019-beats-026-estimate-sales-2031m-beat-1985m-estimate
Neuronetics Q4 GAAP EPS $(0.19) Beats $(0....
03/05/2024 12:31:39

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) b...

earnings-scheduled-for-march-5-2024
Earnings Scheduled For March 5, 2024
03/05/2024 10:00:02

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

earnings-outlook-for-neuronetics
Earnings Outlook For Neuronetics
03/04/2024 18:02:28

neuronetics-reports-fy23-preliminary-unaudited-total-revenue-is-expected-to-be-over-71m-as-compared-to-previously-stated-guidance-of-70m-72m
Neuronetics Reports FY23 Preliminary Unaud...
01/08/2024 13:46:48

Full Year 2023Preliminary unaudited total revenue is expected to be over $71 million as compared to previously stated guidance ...

neuronetics-sees-prelim-q4-total-revenue-20m-vs-previously-stated-guidance-of-19m-21m
Neuronetics Sees Prelim. Q4 Total Revenue ...
01/08/2024 13:36:15

neuronetics-receives-fda-510k-clearance-for-neurosite-coil-placement-accessory-that-simplifies-measurement-and-coil-positioning-during-neurostar-transcranial-magnetic-stimulation-treatments
Neuronetics Receives FDA 510(k) Clearance ...
12/18/2023 13:50:01

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

neuronetics-says-neurostar-tms-receives-expanded-regulatory-approval-in-japan
Neuronetics Says NeuroStar TMS Receives Ex...
12/04/2023 13:57:37

neurostar-elevates-depression-treatment-with-cutting-edge-technology-advancements
NeuroStar Elevates Depression Treatment Wi...
11/13/2023 14:01:50

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

neuronetics-announces-continued-momentum-from-health-plans-for-tms-therapy-coverage
Neuronetics Announces Continued Momentum F...
11/09/2023 13:38:59

Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing ...

neuronetics-sees-q4-fy23-revenues-of-19m-21m-versus-consensus-of-1976m
Neuronetics Sees Q4 FY23 Revenues Of $19M-...
11/07/2023 12:34:55

neuronetics-expects-fy23-revenue-of-70m-72m-versus-prior-guidance-of-69m-73m-and-consensus-of-7050m
Neuronetics Expects FY23 Revenue Of $70M-$...
11/07/2023 12:33:49

neuronetics-shipped-43-neurostar-systems-in-q3
Neuronetics Shipped 43 NeuroStar Systems I...
11/07/2023 12:32:18

neuronetics-q3-eps-033-misses-031-estimate-sales-1788m-beat-1758m-estimate
Neuronetics Q3 EPS $(0.33) Misses $(0.31) ...
11/07/2023 12:31:40

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.31)...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION